[
    [
        {
            "time": "2019-01-24",
            "original_text": "格隆汇港股聚焦(1.24)︱复星医药授出一项新选择权 拟最高4.7亿美元受让印度药企Gland Pharma 22.08%的股份",
            "features": {
                "keywords": [
                    "复星医药",
                    "Gland Pharma",
                    "选择权",
                    "4.7亿美元",
                    "印度药企"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "格隆汇港股聚焦(1.24)︱复星医药授出一项新选择权 拟最高4.7亿美元受让印度药企Gland Pharma 22.08%的股份",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-01-24",
            "original_text": "复星医药(02196.HK)授出一项新选择权 拟最高4.7亿美元受让印度Gland Pharma 22.08%的股份",
            "features": {
                "keywords": [
                    "复星医药",
                    "Gland Pharma",
                    "选择权",
                    "4.7亿美元"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星医药(02196.HK)授出一项新选择权 拟最高4.7亿美元受让印度Gland Pharma 22.08%的股份",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "2019-01-24",
            "original_text": "复星医药(02196-HK)控股子公司抗体注射液获药品注册申请受理",
            "features": {
                "keywords": [
                    "复星医药",
                    "抗体注射液",
                    "注册申请受理"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星医药(02196-HK)控股子公司抗体注射液获药品注册申请受理",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-01-24",
            "original_text": "复星医药(02196.HK)类风湿性关节炎新药获注册受理",
            "features": {
                "keywords": [
                    "复星医药",
                    "类风湿性关节炎",
                    "新药",
                    "注册受理"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星医药(02196.HK)类风湿性关节炎新药获注册受理",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-01-24",
            "original_text": "股市早知道:科创板和注册制来了 房企发40亿美元债",
            "features": {
                "keywords": [
                    "科创板",
                    "注册制",
                    "房企",
                    "40亿美元债"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "房地产",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "股市早知道:科创板和注册制来了 房企发40亿美元债",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-01-24",
            "original_text": "财闻点金｜中央深改委召开会议 通过设立科创板总体实施方案",
            "features": {
                "keywords": [
                    "中央深改委",
                    "科创板",
                    "总体实施方案"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "财闻点金｜中央深改委召开会议 通过设立科创板总体实施方案",
                "Correlation": 2,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-01-24",
            "original_text": "华创事件驱动早报1-24：科创板及试点注册制总体方案获通过；海南将编制出台多项旅游规划",
            "features": {
                "keywords": [
                    "科创板",
                    "注册制",
                    "海南",
                    "旅游规划"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技",
                    "旅游"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华创事件驱动早报1-24：科创板及试点注册制总体方案获通过；海南将编制出台多项旅游规划",
                "Correlation": 2,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-01-24",
            "original_text": "【山证早班车】山西证券晨会纪要（20190124）",
            "features": {
                "keywords": [
                    "山西证券",
                    "晨会纪要"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【山证早班车】山西证券晨会纪要（20190124）",
                "Correlation": 1,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 1,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        }
    ]
]